Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Non-Current Debt (2020 - 2025)

GeneDx Holdings has reported Non-Current Debt over the past 6 years, most recently at $48.2 million for Q4 2025.

  • Quarterly results put Non-Current Debt at $48.2 million for Q4 2025, down 7.2% from a year ago — trailing twelve months through Dec 2025 was $48.2 million (down 7.2% YoY), and the annual figure for FY2025 was $48.2 million, down 7.2%.
  • Non-Current Debt for Q4 2025 was $48.2 million at GeneDx Holdings, down from $51.6 million in the prior quarter.
  • Over the last five years, Non-Current Debt for WGSWW hit a ceiling of $52.7 million in Q4 2023 and a floor of $6.1 million in Q3 2023.
  • Median Non-Current Debt over the past 5 years was $18.3 million (2021), compared with a mean of $29.0 million.
  • Biggest five-year swings in Non-Current Debt: tumbled 43.18% in 2022 and later soared 759.78% in 2024.
  • GeneDx Holdings' Non-Current Debt stood at $11.0 million in 2021, then tumbled by 43.18% to $6.2 million in 2022, then surged by 743.01% to $52.7 million in 2023, then dropped by 1.47% to $51.9 million in 2024, then dropped by 7.2% to $48.2 million in 2025.
  • The last three reported values for Non-Current Debt were $48.2 million (Q4 2025), $51.6 million (Q3 2025), and $51.7 million (Q2 2025) per Business Quant data.